Hua Medicine

Hua Medicine company information, Employees & Contact Information

Explore related pages

Related company profiles:

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on novel therapies for the treatment of diabetes and CNS disorders. In order to meet the highest international standards, Hua Medince developed a powerful internal research quality supervision system Q (QC/QA) based on the advanced open innovation model VIC (VC + IP + CRO).

Company Details

Employees
55
Address
Shanghai, Shanghai
Phone
+86 21 5886 9997
Email
BD****@****ine.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Shanghai, Shanghai
Looking for a particular Hua Medicine employee's phone or email?

Hua Medicine Questions

News

Hua Medicine Announces 2025 Interim Results - Yahoo Finance

Hua Medicine Announces 2025 Interim Results Yahoo Finance

Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis - ACN Newswire

Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis ACN Newswire

China's Hua Medicine Sinks After Ending Diabetes Drug Distribution Tie-Up With Bayer - 一财全球Yicai Global

China's Hua Medicine Sinks After Ending Diabetes Drug Distribution Tie-Up With Bayer 一财全球Yicai Global

Hua Medicine plans to focus T2D drug on diabetic kidney disease patients - Clinical Trials Arena

Hua Medicine plans to focus T2D drug on diabetic kidney disease patients Clinical Trials Arena

Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial - Nature

Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial Nature

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain - Fierce Pharma

Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug, but commercial value uncertain Fierce Pharma

Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' - ACN Newswire

Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' ACN Newswire

Top Hua Medicine Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant